Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomarkers in angina.

Paul O Collinson1

  • 1Dept Chemical Pathology, Cardiology, St George's Hospital and Medical School, London, UK.

Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|August 23, 2005
PubMed
Summary

Atherothrombotic disease, starting as angina, can lead to myocardial infarction. Biomarkers like B-type natriuretic peptide and ischemia-modified albumin show promise for predicting cardiac events and early ischemia detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current and Future Indication for Testing and Use of Cardiac Troponin in Children.

Clinical chemistry·2026
Same author

Modifiers of the effectiveness of point-of-care troponin testing and determinants of concordance between diagnostic pathway recommendations and disposition in patients with chest pain: a post hoc analysis of a randomised controlled trial.

Emergency medicine journal : EMJ·2026
Same author

Taking assessment to the patient: can we break the emergency department gridlock?

Heart (British Cardiac Society)·2026
Same author

Evidence-based implementation of accelerated diagnostic pathway: time for a change.

Heart (British Cardiac Society)·2025
Same author

Analytical Error of Cardiac Troponin and Impact on the Performance of Accelerated Diagnostic Protocols in Patients with Acute Chest Pain.

Clinical chemistry·2025
Same author

The Dilemma of Finding a Young Patient with a Raised Cholesterol Concentration.

The journal of applied laboratory medicine·2025

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomarker Research

Background:

  • Angina is the initial symptomatic stage of atherothrombotic disease, preceding myocardial infarction.
  • Plaque development is linked to traditional risk factors, with progression driven by plaque destabilization and rupture.
  • Inflammatory markers like C-reactive protein predict cardiac events, but B-type natriuretic peptide is a potent predictor of cardiovascular mortality.

Purpose of the Study:

  • To review the continuum of atherothrombotic disease from angina to myocardial infarction.
  • To highlight the role of inflammatory markers and peptide hormones in disease progression and risk stratification.
  • To identify promising biomarkers for early detection of myocardial ischemia.

Main Methods:

  • Literature review of atherothrombotic disease progression.
  • Analysis of the predictive value of inflammatory markers and cardiac biomarkers.
  • Evaluation of emerging markers for ischemia detection.

Main Results:

  • B-type natriuretic peptide is identified as the most powerful predictor of cardiovascular mortality, reflecting its role in cardiac neuroendocrine integration.
  • Ischemia-modified albumin shows potential as a marker for early ischemia detection upon presentation.
  • The progression from plaque rupture to myocardial ischemia and infarction is a continuous process.

Conclusions:

  • Understanding the continuum of atherothrombotic disease is crucial for risk stratification and intervention.
  • Biomarkers play a key role in predicting cardiovascular events and guiding clinical management.
  • Ischemia-modified albumin represents a promising avenue for early diagnosis of myocardial ischemia.

Related Experiment Videos